No spam - just the good stuff

Subscribe to our newsletter

News

Telomeres

Healthy aging signs in telomeres found in new supplement study

Hyperbaric oxygen therapy: a commercial Longevity treatment?

Telomere length, frailty and death

Pivotal Spanish study finds that telomere length lacks association with aging, yet frailty reflects mortality.

Inflammaging – could ibuprofen be the answer?

NAD-boosting may stabilise telomeres to slow aging

Telomere length variations in tissue have implications for Longevity

Exclusive interview: Professor Richard Faragher and cellular senescence

Telomeres – it’s not the end of the line

Global investment consortium slated to back Telocyte into Phase 1

Telomeres on repeat to inhibit inflamm-aging

Chinese medicine plant activates telomerase

Exclusive interview: The dynamics of telomeres

Correlation between telomere length and brain age

Pay-to-play age reduction has $1m price tag

Telomeres extend lifespan without genetic mods

Telomere shortening tied to structural changes in the brain

New study reveals Telomerase in adult cells slows aging

Discovery shows telomere-shortening rate is a vital predictor

New treatment stalls cellular aging and promotes rejuvination

Stanford anouces significant telomere research

Scientists link telomeres with age-related disease

Find us here ...

Subscribe to our newsletter

© Copyright 2023 FIRST LONGEVITY Limited. All rights reserved. FIRST LONGEVITY

The information included in this website is for informational purposes only: its purpose is to promote a broad consumer understanding a knowledge of various health topics. It is not intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen, and never disregard professional medical advice or delay in seeking it because of something you have read on this website.

DISCLAIMER FOR U.S. BASED INVESTORS

The Agent of First Longevity Limited in the United States is Marco Polo Securities Inc, a non-affiliated broker-dealer registered with the US Securities and Exchange Commission. The activities of First Longevity Limited in the United States will be affected only to the extent permitted by Rule 15a-6 under the US Securities Exchange Act of 1934 and in accordance with the Services Agreement entered into between First Longevity Limited and Marco Polo Securities Inc with respect thereto. Contact at Marco Polo Securities is clientservices@mpsecurities.com; 1-347-745-6448.